Pharmaceutical company shareholders were “spooked” this week after President-elect Donald Trump announced that he would ...

A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.

The government version says: “First, do not harm Big Pharma’a huge profits ... The US had the worst COVID outcomes in the industrialized world, along with Canada and England. Our Dedicated Public ...

Valiant souls who have recently read the Margaret Atwood trilogy on which this new Wayne McGregor piece for the Royal Ballet ...

Good afternoon, and thank you for joining the ReShape Lifesciences Third Quarter 2024 Conference Call. I would like to turn the call over to Michael Miller from Rx Communications. Good afternoon, ...

United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...

Shyra Gardai, chief scientific officer at the molecular glue start-up EpiBiologics, says Big Pharma’s recent interest in glue ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

With biomanufacturing often a limiting factor for drug developers, Canada’s Future Fields is heralding its bug-based approach ...

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Pfizer sales rose 31% to $17.7 billion in the third quarter of 2024, driven by a surge in demand for the pharma giant’s COVID-19 medications. AbbVie announced Monday that it is buying Aliada ...